This analysis validates the Polar Fitness Test against cardiopulmonary exercise testing and 6MWT for estimating V̇O2max in individuals with cardiovascular risks.
The Polar Fitness Test (PFT) estimates maximal oxygen consumption (V̇O2max) under resting conditions using heart rate data from the manufacturer’s wearable devices. We aimed to validate the PFT in a population with cardiovascular risk factors and to compare its results with five established equations predicting V̇O2max based on the 6-min walk test (6MWT). Twenty-four participants (9 female; age 57.4 ± 10.2 years) undergoing medically supervised exercise training—including seven individuals on heart rate-limiting medication—completed the PFT, 6MWT, and cardiopulmonary exercise testing (CPET), which served as the criterion V̇O2max measurement. The PFT showed a mean absolute percent-age error (MAPE) of 13.7%, an intraclass correlation coefficient (ICC) of 0.743, a mean bias of −1.0 mL/min/kg, and limits of agreement (LoA) of ±11.4 mL/min/kg compared to CPET. Among the 6MWT-based equations, only the Porcari equation demonstrated similar performance (MAPE 12.6%, ICC 0.725, mean bias 0.2 mL/min/kg, LoA ± 9.7 mL/min/kg), while other equations showed larger errors and systematic deviations. Our data indicate that the PFT may present an easily accessible option to estimate V̇O2max on population level when exercise-based testing is not feasible. However, its variability limits use for individual clinical decisions, reaffirming the relevance of CPET for accurate assessment.
No takes yet. Share an insight, caveat, or question.
Neudorfer et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: